Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00036140 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00036140: Completed Phase 1 study, sponsored by Pfizer.
NCT00036140 is a Phase 1 study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00036140, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
Interventions
- DRUG Investigational drug
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
What the finished NCT00036140 record still lists
NCT00036140 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Investigational drug is the first listed.
NCT00036140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00036140 about?
NCT00036140 is a clinical study titled "Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma". The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
What is the current status of trial NCT00036140?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00036140?
The interventions under investigation include: Investigational drug (DRUG).
Who is sponsoring clinical trial NCT00036140?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.